4.8 Article

Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis

期刊

GUT
卷 62, 期 2, 页码 310-316

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2011-301008

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft [VE: KFO210, SFB-TR17]
  2. LOEWE-Schwerpunkt 'Tumour and Inflammation'
  3. Max-Eder program of the German Cancer Research Foundation [VE: 70-3022-El I]
  4. Novartis Foundation
  5. Schulze Center for Novel Therapeutics
  6. Mayo Clinic Cancer Center
  7. National Institutes of Health [CA136526]
  8. Mayo Clinic Pancreatic SPORE [P50 CA102701]
  9. Mayo Clinic Center for Cell Signalling in Gastroenterology [P30 DK84567]

向作者/读者索取更多资源

Transcription factors are proteins that regulate gene expression by modulating the synthesis of messenger RNA. Since this process is often one dominant control point in the production of many proteins, transcription factors represent the key regulators of numerous cellular functions, including proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterised by activation of inflammatory signalling pathways converging on a limited set of transcription factors that fine-tune gene expression patterns contributing to the growth and maintenance of these tumours. Thus strategies targeting these transcriptional networks activated in pancreatic cancer cells could block the effects of upstream inflammatory responses participating in pancreatic tumorigenesis. The authors review this field of research and summarise current strategies for targeting oncogenic transcription factors and their activating signalling networks in the treatment of pancreatic cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据